Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects

NCT02791815 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Midazolam
DRUG: Selexipag

Sponsor

Actelion